These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 23680890)

  • 21. Technology and the issue of cost/benefit in diabetes.
    Giannini C; Mohn A; Chiarelli F
    Diabetes Metab Res Rev; 2009 Sep; 25 Suppl 1():S34-44. PubMed ID: 19662616
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moderately overweight and obese patients in general practice: a population based survey.
    van Dijk L; Otters HB; Schuit AJ
    BMC Fam Pract; 2006 Jul; 7():43. PubMed ID: 16827937
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The burden of diabetes in Africa: a major public health problem].
    Jaffiol C
    Bull Acad Natl Med; 2011 Jun; 195(6):1239-53; discussion 1253-4. PubMed ID: 22530517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comorbidities associated with the increasing burden of hepatitis C infection.
    Basseri B; Yamini D; Chee G; Enayati PD; Tran T; Poordad F
    Liver Int; 2010 Aug; 30(7):1012-8. PubMed ID: 20408945
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The economic burden of diabetes.
    Dall TM; Zhang Y; Chen YJ; Quick WW; Yang WG; Fogli J
    Health Aff (Millwood); 2010 Feb; 29(2):297-303. PubMed ID: 20075080
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional case studies--Africa.
    Prentice AM
    Nestle Nutr Workshop Ser Pediatr Program; 2009; 63():33-41; discussion 41-6, 259-68. PubMed ID: 19346766
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Glucose intolerance (diabetes and IGT) in a selected South Indian population with special reference to family history, obesity and lifestyle factors--the Chennai Urban Population Study (CUPS 14).
    Mohan V; Shanthirani CS; Deepa R
    J Assoc Physicians India; 2003 Aug; 51():771-7. PubMed ID: 14651136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Noncommunicable diseases in sub-Saharan Africa: where do they feature in the health research agenda?
    Unwin N; Setel P; Rashid S; Mugusi F; Mbanya JC; Kitange H; Hayes L; Edwards R; Aspray T; Alberti KG
    Bull World Health Organ; 2001; 79(10):947-53. PubMed ID: 11693977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Economic costs of diabetes in the U.S. In 2007.
    American Diabetes Association
    Diabetes Care; 2008 Mar; 31(3):596-615. PubMed ID: 18308683
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cost of diabetes and its complications in Thailand: a complete picture of economic burden.
    Chatterjee S; Riewpaiboon A; Piyauthakit P; Riewpaiboon W; Boupaijit K; Panpuwong N; Archavanuntagul V
    Health Soc Care Community; 2011 May; 19(3):289-98. PubMed ID: 21276105
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The obesity-driven rising costs of type 2 diabetes in Australia: projections from the Fremantle Diabetes Study.
    Davis WA; Knuiman MW; Hendrie D; Davis TM
    Intern Med J; 2006 Mar; 36(3):155-61. PubMed ID: 16503950
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diabesity: an overview of a rising epidemic.
    Farag YM; Gaballa MR
    Nephrol Dial Transplant; 2011 Jan; 26(1):28-35. PubMed ID: 21045078
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Lifestyle, socioeconomic status and morbidity in postmenopausal women with grade II and III obesity].
    Navarro Rodríguez MC; Saavedra Santana P; de Pablos Velasco P; Sablón González N; de Miguel Ruiz E; Castro Medina R; Sosa Henríquez M
    Endocrinol Nutr; 2009 May; 56(5):227-32. PubMed ID: 19627743
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epidemiologic and economic consequences of the global epidemics of obesity and diabetes.
    Yach D; Stuckler D; Brownell KD
    Nat Med; 2006 Jan; 12(1):62-6. PubMed ID: 16397571
    [No Abstract]   [Full Text] [Related]  

  • 35. The impact of diabetes mellitus on healthcare costs in Italy.
    Giorda CB; Manicardi V; Diago Cabezudo J
    Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-19. PubMed ID: 22098288
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevalence of cardiovascular risk factors in a middle-income country and estimated cost of a treatment strategy.
    Bovet P; Shamlaye C; Gabriel A; Riesen W; Paccaud F
    BMC Public Health; 2006 Jan; 6():9. PubMed ID: 16423280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk factors and disease prevalence in 3331 personal check-ups performed in preventive medicine between 2006 and 2011. cross-sectional and follow-up study.
    Keipes M; Bellucci A; Hansen E
    Bull Soc Sci Med Grand Duche Luxemb; 2012; (2):25-35. PubMed ID: 23362564
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The burden of metabolic diseases amongst HIV positive patients on HAART attending The Johannesburg Hospital.
    Julius H; Basu D; Ricci E; Wing J; Basu JK; Pocaterra D; Bonfanti P
    Curr HIV Res; 2011 Jun; 9(4):247-52. PubMed ID: 21631427
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevalence of selected risk behaviors and chronic diseases and conditions-steps communities, United States, 2006-2007.
    Cory S; Ussery-Hall A; Griffin-Blake S; Easton A; Vigeant J; Balluz L; Garvin W; Greenlund K;
    MMWR Surveill Summ; 2010 Sep; 59(8):1-37. PubMed ID: 20864923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Disease management programme for diabetes mellitus in Nepal.
    Dulal RK; Karki S
    JNMA J Nepal Med Assoc; 2009; 48(176):281-6. PubMed ID: 21105550
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.